News & information from UB, New York's flagship university
For help reaching an expert on deadline, please contact UB's media relations team at 716-645-6969 or ub-news@buffalo.edu.
Note to members of the news media:
The correct name of the university is “University at Buffalo,” not “University of Buffalo.”
Thomas A. Russo
Chief of the Division of Infectious Diseases in the Department of Medicine
Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
AREAS OF EXPERTISE:
Infectious diseases; superbugs; antibiotic resistance; drug and vaccine development
Russo can discuss various infectious diseases, including COVID-19. He is an expert on all aspects of infectious disease, including epidemiology, clinical disease, treatment and prevention.
He conducts research on gram-negative bacterial infections, including new, hypervirulent variants of bacteria that are becoming resistant to antibiotics. He also works on vaccines and drug development targeted against these infections.
Russo was lead author on a paper that reported on his team’s discovery of biomarkers that can help distinguish the hypervirulent Klebsiella pneumoniae from the more common, less virulent strain. The discovery makes possible a diagnostic test for this hypervirulent strain.
CONTACT:
Thomas A. Russo, MD
Chief of the Division of Infectious Diseases in the Department of Medicine, Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
SUNY Distinguished Professor of Medicine, Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
- 716-829-2674. Russo can also be reached through Ellen Goldbaum in University Communications at 716-645-4605 or goldbaum@buffalo.edu, or Douglas Sitler in University Communications at 716-645-9069 or drsitler@buffalo.edu.
- trusso@buffalo.edu
- Thomas A. Russo’s website